Chest tube painkiller may ease recovery after lung surgery

NCT ID NCT07393386

Not yet recruiting Symptom relief Sponsor: Shanghai Pulmonary Hospital, Shanghai, China Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests if giving the numbing drug bupivacaine through a chest tube can reduce pain after minimally invasive lung surgery. About 249 adults having video-assisted thoracoscopic surgery will receive either a low or high dose of bupivacaine, or a placebo. The main goal is to see if it lowers pain during coughing in the first two days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine
What this could lead to: If it works, this could provide a better way to manage pain after lung surgery, reducing the need for opioids and speeding up recovery.
What could go wrong: This is a single-center, early-phase trial. The results may not apply to all patients, and there is a risk of side effects from bupivacaine, such as nerve or heart issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAIN MANAGEMENT

Contacts and locations

Locations

Shanghai Pulmonary Hospital

Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.